Puma Biotechnology shareholders approve 3M share increase for equity plan, elect directors

PUMA BIOTECHNOLOGY, INC.

Shareholders approved amendment to increase shares under 2011 plan by 3M to 17,529,412; ISO grants extended to March 2034.
All eight director nominees elected: Auerbach, Cesano, Dorval, Miller, Moyes, Senderowicz, Stuglik, Wilson.
Ratified KPMG as independent auditor for fiscal 2024 with 40.2M votes for.
Advisory say-on-pay approved with 30.7M for; board adopts annual frequency for future votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.